Literature DB >> 647639

Well differentiated adenocarcinoma of the prostate.

W H Kern.   

Abstract

One hundred and one adenocarcinomas of the prostate that over a five-year period had been classified as being "well differentiated" or "grade 1" were reviewed and reclassified. Thirty-eight of the cases met strict criteria for such a classification. Twenty-six patients died of prostatic carcinoma. Seventy-five patients (74%) survived for five years, including 87% of the patients with clearly well differentiated carcinomas and 67% of those with somewhat less differentiated tumors. Forty-six percent of all patients including 22 of the 38 well differentiated review cases (58%) are now alive 7-11 years after prostatectomy without evidence of residual disease. Grading appears to be useful and the prognosis of well differentiated carcinomas is better than average but some cases even if focal and incidentally found will terminate with disseminated disease, usually more than five years after the original diagnosis.

Entities:  

Mesh:

Year:  1978        PMID: 647639     DOI: 10.1002/1097-0142(197805)41:5<2046::aid-cncr2820410553>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  Prostatic carcinoma: aspects of pathology, prognosis, and therapy.

Authors:  H Kastendieck
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

2.  Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer.

Authors:  J H Blom; F J Ten Kate; F H Schroeder; R O van der Heul
Journal:  Urol Res       Date:  1990

3.  Biological tissue markers in benign and malignant disease of the human prostate.

Authors:  P Chastonay; J Hurlimann; D Gardiol
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.